Ethanolic Extract of Kinkeliba (Combretum micranthum), Rich in Phenolic Compounds Mitigates DSS-Induced Ulcerative Colitis in C57BL/6 Mice via Antioxidation and Microbiota Regulation

Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract, and current therapies are limited by adverse side effects. <i>Combretum micranthum</i> G. Don (kinkeliba), a medicinal plant traditionally used in West Africa, has been reported to possess pharmacological activities and a favorable safety profile. In this study, an ethanolic extract of <i>Combretum micranthum</i> (EECM) was characterized using HPLC-DAD-ESI-MS to identify its phenolic constituents. Acute colitis was induced in C57BL/6 mice using 3% DSS, while EECM (100 and 200 mg/kg) was administered orally for seven days. Disease Activity Index was monitored daily, and colonic injuries were evaluated through macroscopic and histological analyses, as well as hematological and biochemical assessments. In vitro, EECM contained 293.54 mg/g of total phenolic compounds and showed strong antioxidant activity in DPPH, ABTS, and FRAP assays. Furthermore, the extract exhibited antibacterial activity against <i>Bacillus subtilis</i>, <i>Staphylococcus aureus</i>, <i>Salmonella enterica</i>, and <i>Streptococcus pyogenes</i> at various concentrations. In contrast, <i>Enterococcus faecalis</i>, <i>Escherichia coli</i>, and <i>Pseudomonas aeruginosa</i> were not affected at the tested concentrations. No antifungal activity was detected against the filamentous fungus <i>Aspergillus brasiliensis</i> and the yeasts <i>Saccharomyces cerevisiae</i>, <i>Candida parapsilosis</i>, and <i>Candida albicans</i>. In vivo, EECM alleviated the clinical signs of colitis, reduced histological damage, and modulated hematological and biochemical parameters. Overall, EECM exhibited significant antioxidant and anti-inflammatory activities and may represent a promising natural candidate for IBD management. Further investigations into chronic experimental models are necessary to establish their therapeutic relevance.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2025-11-22
DOI
https://doi.org/10.3390/ijms262311299
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ethanolic Extract of Kinkeliba (Combretum micranthum), Rich in Phenolic Compounds Mitigates DSS-Induced Ulcerative Colitis in C57BL/6 Mice via Antioxidation and Microbiota Regulation

Dan Cristian Vodnar, D. Hodor, Alina-Diana Hașaș, Meriem Aziez et al.
International Journal of Molecular Sciences
Inflammatory Bowel Disease
article

Ethanolic Extract of Kinkeliba (Combretum micranthum), Rich in Phenolic Compounds Mitigates DSS-Induced Ulcerative Colitis in C57BL/6 Mice via Antioxidation and Microbiota Regulation

Dan Cristian Vodnar, D. Hodor, Alina-Diana Hașaș, Meriem Aziez, Gheorghe Adrian Martău, Flaviu Tăbăran, Ibrahima Mamadou Sall
article en

Abstract

Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract, and current therapies are limited by adverse side effects. <i>Combretum micranthum</i> G. Don (kinkeliba), a medicinal plant traditionally used in West Africa, has been reported to possess pharmacological activities and a favorable safety profile. In this study, an ethanolic extract of <i>Combretum micranthum</i> (EECM) was characterized using HPLC-DAD-ESI-MS to identify its phenolic constituents. Acute colitis was induced in C57BL/6 mice using 3% DSS, while EECM (100 and 200 mg/kg) was administered orally for seven days. Disease Activity Index was monitored daily, and colonic injuries were evaluated through macroscopic and histological analyses, as well as hematological and biochemical assessments. In vitro, EECM contained 293.54 mg/g of total phenolic compounds and showed strong antioxidant activity in DPPH, ABTS, and FRAP assays. Furthermore, the extract exhibited antibacterial activity against <i>Bacillus subtilis</i>, <i>Staphylococcus aureus</i>, <i>Salmonella enterica</i>, and <i>Streptococcus pyogenes</i> at various concentrations. In contrast, <i>Enterococcus faecalis</i>, <i>Escherichia coli</i>, and <i>Pseudomonas aeruginosa</i> were not affected at the tested concentrations. No antifungal activity was detected against the filamentous fungus <i>Aspergillus brasiliensis</i> and the yeasts <i>Saccharomyces cerevisiae</i>, <i>Candida parapsilosis</i>, and <i>Candida albicans</i>. In vivo, EECM alleviated the clinical signs of colitis, reduced histological damage, and modulated hematological and biochemical parameters. Overall, EECM exhibited significant antioxidant and anti-inflammatory activities and may represent a promising natural candidate for IBD management. Further investigations into chronic experimental models are necessary to establish their therapeutic relevance.

International Journal of Molecular SciencesVol. 26(23)
University of Béjaïa (DZ), University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca (RO)
Openalex Percentile: Top 62%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.